Upcoming Opportunities

Fundamentals of R for Biological Scientists Virtual Workshop
 
Fundamentals of R for Biological Scientists Virtual Workshop
Handling large biological datasets is now a routine activity for researchers in the cancer and regenerative medicine fields. R is a popular scripting language that has become a common tool for managing biological datasets, however the flexibility and power of R can be difficult to navigate for new users. To assist researchers, BioCanRx and Stem Cell Network are partnering to provide a multi-session introductory workshop that will equip scientists with the fundamental knowledge to use R in their research. The workshop is intended for researchers who have little or no programming experience. Please note, this workshop will be offered in English only.
 
Workshop dates: This virtual workshop comprises four 60-90-minute sessions which run weekly on Wednesday, September 22, 29, October 6 and 13, 2021 at 2:00 p.m. Eastern Time (11:00 a.m. PT).
 
Application Deadline: Thursday, August 26, 2021
 
Click here for additional program details
Click here for the application documents

 

Sharing Multi-network Resources for Trainee Success (SMRTS) Seminars Program
Ongoing | Online
 
The SMRTS (Sharing Multi-network Resources for Trainee Success) Seminars Program is a professional development initiative between 9 national and provincial networks aimed at providing the best possible programming to our respective trainees.
 
Each month, we will offer our trainees access to a wide range of soft skills programming through a live-streamed webinar or event.
 
Past topics have included: grant writing strategy, media relations, patents and intellectual property, and communicating in plain language.
 
Click here to learn more about SMRTS Seminars Program. 

 

Past Events

 

Best Practices for Therapeutic Translation: Optimizing Pre-Clinical Research Rigor and Reproducibility
February 25-26, 2020 | Toronto, Ontario
 
Learn More

 

Navigating the Regulatory Steps in Biotherapeutic Translation Workshop
January 16-17, 2020 | Ottawa, Ontario
 
Learn More

 

Summit for Cancer Immunotherapy
October 20-23, 2019 | Victoria, B.C.
 
Each year, BioCanRx will provide travel support (up to $1,200 CAD) for up to 100 HQP to attend Summit4CI through a conference abstract competition. Abstract submission is now open for Summit4CI 2019. Learn more: https://cancersummit.ca/abstracts/key-dates-and-details
 
Summit4CI 2018 took place October 27-30, 2018 in Banff, Alberta.
 
Summit4CI 2017 took place June 25-28, 2017 in Gatineau, Quebec.
 
For more information, visit www.cancersummit.ca.

 

Sharing Best Practices in GMP Manufacturing: Peer-to-Peer Webinar Series
Date TBC, 2018 | Online
 
This is a knowledge sharing webinar series co-created with GMP manufacturing staff from the BioCanRx network. The purpose of the program is to enhance the skills and competencies of network technical staff through monthly webinars. During these webinars, BioCanRx manufacturing teams or external consultants share best practices in a “round table” discussion format.
 
Contributing members include:

  • Biotherapeutics Manufacturing Facility, Ottawa Hospital Research Institute, Ottawa, Ontario
  • Tumour Immunotherapy Lab, Princess Margaret Cancer Centre, Toronto, Ontario
  • Alberta Cell Therapy Manufacturing, University of Alberta, Edmonton, Alberta
  • Cell Production Facility, BCCA’s Deeley Research Centre, Victoria, British Columbia

 

If you or your research team are interested in participating in this webinar series, apply here.

 

Working with Patients to Inform Early-phase Cancer Clinical Trial Design
March 8, 2017 | Montreal, Quebec

 

This half-day workshop outlined what patient-oriented research (POR) is, how it is used to inform and impact clinical trials currently, how BioCanRx intends to conduct patient-oriented research to inform cancer clinical trial design, and provided ways for patients to get involved.

 

BioCanRx network investigators highlighted how they intend to engage patients to inform early-phase clinical trial design of the first Made-in-Canada CAR-T therapy.